Published in Eur Respir J on April 01, 1998
Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 2.19
Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+). Thorax (2003) 1.03
Flow cytometry of sputum: assessing inflammation and immune response elements in the bronchial airways. Inhal Toxicol (2011) 1.02
IL-13-producing BLT1-positive CD8 cells are increased in asthma and are associated with airway obstruction. Allergy (2013) 0.92
Patterns of inflammation and the use of reversibility testing in smokers with airway complaints. BMC Pulm Med (2006) 0.79
Circadian changes in the sputum of asthmatic subjects and healthy controls. World Allergy Organ J (2008) 0.77
Assessment of airway inflammation with exhaled NO measurement. Hippokratia (2007) 0.77
Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy (1977) 14.37
Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet (1968) 5.08
Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax (1978) 4.77
IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest (1998) 4.77
Bird breeder's (fancier's) lung. Lancet (1966) 4.68
Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy (1977) 4.42
Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax (1992) 4.30
The perception of breathlessness in asthma. Am Rev Respir Dis (1982) 4.17
Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol (1981) 4.03
Mites and house-dust allergy. Lancet (1968) 4.01
The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85
Allergic reactions of the lungs to enzymes of Bacillus subtilis. Lancet (1969) 3.59
Allergenic pollen and pollen allergy in Europe. Allergy (2007) 3.58
The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (1990) 3.40
Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest (1998) 3.37
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J (2006) 3.09
Fluorescent pigments in corals are photoprotective. Nature (2000) 3.08
Chronic cough: eosinophilic bronchitis without asthma. Lancet (1989) 3.07
Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax (1981) 3.06
Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol (1982) 2.84
Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis (1981) 2.75
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy (1994) 2.58
Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax (1982) 2.53
Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J (1996) 2.46
Acute asthma: emergency department management and prospective evaluation of outcome. CMAJ (1990) 2.45
Diagnostic testing in chronic urticaria and angioedema. CMAJ (1992) 2.27
Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis (1990) 2.23
High levels of Epstein-Barr virus in COPD. Eur Respir J (2008) 2.16
Late asthmatic responses. Am Rev Respir Dis (1987) 2.05
Protective effect of drugs on histamine-induced asthma. Thorax (1977) 2.02
The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol (1970) 1.97
Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med (1996) 1.97
Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol (1973) 1.96
Nonvalidated food allergy tests. CMAJ (1988) 1.94
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy (1997) 1.92
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med (1998) 1.90
Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. CMAJ (1999) 1.84
Candida albicans precipitins in respiratory disease in man. J Allergy (1968) 1.82
Canadian Thoracic Society guidelines for occupational asthma. Can Respir J (1998) 1.80
A method of rating behaviour characteristics for use in large scale surveys of mental handicap. Psychol Med (1973) 1.73
Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med (1998) 1.72
The spectrum of IgE-mediated responses to latex. JAMA (1991) 1.71
Fatal reaction to peanut antigen in almond icing. CMAJ (1988) 1.70
Standardised methodology of sputum induction and processing. Eur Respir J Suppl (2002) 1.70
Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J (2000) 1.69
Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J (1999) 1.68
Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol (1983) 1.67
Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol (1996) 1.66
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol (1983) 1.65
Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness. Eur Respir J (1993) 1.65
Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Mol Cell Biol (1999) 1.64
Exacerbations of asthma without sputum eosinophilia. Thorax (1995) 1.63
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62
Asthma, COPD and bronchitis are just components of airway disease. Eur Respir J (2006) 1.60
Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol (1979) 1.60
Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther (1979) 1.60
Human lung fibroblast-derived granulocyte-macrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro. Am J Respir Cell Mol Biol (1989) 1.58
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer (2000) 1.57
Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis (1979) 1.57
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55